GMAB
Price
$23.31
Change
+$0.33 (+1.44%)
Updated
Aug 15 closing price
Capitalization
14.08B
80 days until earnings call
VALN
Price
$11.53
Change
+$1.06 (+10.12%)
Updated
Aug 15 closing price
Capitalization
878.78M
87 days until earnings call
Interact to see
Advertisement

GMAB vs VALN

Header iconGMAB vs VALN Comparison
Open Charts GMAB vs VALNBanner chart's image
Genmab A/S ADS
Price$23.31
Change+$0.33 (+1.44%)
Volume$1.49M
Capitalization14.08B
Valneva SE
Price$11.53
Change+$1.06 (+10.12%)
Volume$107.83K
Capitalization878.78M
GMAB vs VALN Comparison Chart in %
Loading...
GMAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VALN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GMAB vs. VALN commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMAB is a Hold and VALN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2025
Stock price -- (GMAB: $23.31 vs. VALN: $11.53)
Brand notoriety: GMAB and VALN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GMAB: 111% vs. VALN: 218%
Market capitalization -- GMAB: $14.08B vs. VALN: $878.78M
GMAB [@Biotechnology] is valued at $14.08B. VALN’s [@Biotechnology] market capitalization is $878.78M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.71B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GMAB’s FA Score shows that 0 FA rating(s) are green whileVALN’s FA Score has 1 green FA rating(s).

  • GMAB’s FA Score: 0 green, 5 red.
  • VALN’s FA Score: 1 green, 4 red.
According to our system of comparison, GMAB is a better buy in the long-term than VALN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GMAB’s TA Score shows that 7 TA indicator(s) are bullish while VALN’s TA Score has 4 bullish TA indicator(s).

  • GMAB’s TA Score: 7 bullish, 4 bearish.
  • VALN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, GMAB is a better buy in the short-term than VALN.

Price Growth

GMAB (@Biotechnology) experienced а +8.77% price change this week, while VALN (@Biotechnology) price change was +26.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.94%. For the same industry, the average monthly price growth was +21.39%, and the average quarterly price growth was +21.23%.

Reported Earning Dates

GMAB is expected to report earnings on Nov 06, 2025.

VALN is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Biotechnology (+5.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GMAB($14.1B) has a higher market cap than VALN($879M). VALN YTD gains are higher at: 163.724 vs. GMAB (11.691). GMAB has higher annual earnings (EBITDA): 1.35B vs. VALN (-55.24M). GMAB has more cash in the bank: 3.23B vs. VALN (153M). GMAB has less debt than VALN: GMAB (143M) vs VALN (211M). GMAB has higher revenues than VALN: GMAB (3.12B) vs VALN (186M).
GMABVALNGMAB / VALN
Capitalization14.1B879M1,604%
EBITDA1.35B-55.24M-2,447%
Gain YTD11.691163.7247%
P/E Ratio12.06N/A-
Revenue3.12B186M1,675%
Total Cash3.23B153M2,108%
Total Debt143M211M68%
FUNDAMENTALS RATINGS
GMAB: Fundamental Ratings
GMAB
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
42
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
93
SEASONALITY SCORE
1..100
47

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GMABVALN
RSI
ODDS (%)
Bearish Trend 4 days ago
68%
Bearish Trend 4 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
71%
Bearish Trend 4 days ago
85%
Momentum
ODDS (%)
Bullish Trend 4 days ago
57%
N/A
MACD
ODDS (%)
Bullish Trend 4 days ago
60%
N/A
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
61%
Bullish Trend 4 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
61%
Bullish Trend 4 days ago
77%
Advances
ODDS (%)
Bullish Trend 4 days ago
62%
Bullish Trend 6 days ago
74%
Declines
ODDS (%)
Bearish Trend 8 days ago
69%
Bearish Trend 18 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
77%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
58%
Bullish Trend 4 days ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
GMAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VALN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
HDEF30.010.19
+0.64%
Xtrackers MSCI EAFE High Div Yld Eq ETF
RAYD36.840.06
+0.16%
Rayliant Quantitative Dev Mkt Eq ETF
UTWO48.42N/A
N/A
F/m US Treasury 2 Year Note ETF
ETHA33.15-1.22
-3.55%
iShares Ethereum Trust ETF
TOKE6.08-0.34
-5.34%
Cambria Cannabis ETF

GMAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, GMAB has been loosely correlated with TECH. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if GMAB jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GMAB
1D Price
Change %
GMAB100%
+1.44%
TECH - GMAB
41%
Loosely correlated
-0.26%
ARVN - GMAB
38%
Loosely correlated
+0.14%
IPSC - GMAB
38%
Loosely correlated
+2.15%
IMTX - GMAB
36%
Loosely correlated
+7.29%
NVO - GMAB
35%
Loosely correlated
+2.87%
More

VALN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VALN has been loosely correlated with IMTX. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if VALN jumps, then IMTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VALN
1D Price
Change %
VALN100%
+10.12%
IMTX - VALN
33%
Loosely correlated
+7.29%
BMRN - VALN
33%
Loosely correlated
-0.79%
ORMP - VALN
28%
Poorly correlated
-1.89%
GMAB - VALN
27%
Poorly correlated
+1.44%
RNAC - VALN
27%
Poorly correlated
-0.87%
More